{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-001334","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2025-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.498014+00:00","generated_at":"2026-05-17T21:28:40.592826+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"medium","headline":"Artelo raises ~$9.5M private placement to buy Solana; gets UK MHRA nod for Phase 1 trial","bullets":["Gross proceeds ~$9.475M from 593,252 shares at $10.20 plus prefunded warrants; also issues Market Priced ($10.20) and $50.00 warrants.","Net proceeds from shares will be used to purchase SOL; warrant proceeds for working capital and additional SOL.","UK MHRA provided favorable guidance for first-in-human Phase 1 trial of ART12.11 (CBD:TMP cocrystal) for anxiety/depression.","Offering expected to close Aug 5, 2025; registration statement to be filed within 15 days of closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-001334","json":"https://secwatch.observer/filing/0001640334-25-001334.json","markdown":"https://secwatch.observer/filing/0001640334-25-001334.md","text":"https://secwatch.observer/filing/0001640334-25-001334.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001334/0001640334-25-001334-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001334/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:28:40.592826+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}